This dual action makes tirzepatide a particularly exciting candidate for weight management
10.1210/clinem/dgaa285 J Clin Endocrinol Metab
(2019) Support for people who use Anabolic Androgenic Steroids: A Systematic Scoping Review into what they want and what they access
If youre worried, you can talk to your doctor about alternative non-oral contraceptives such as the vaginal ring, the implant, an IUD , or the shot
In 2024, the global GLP-1 drug market is estimated to be worth $53.46 billion and is expected to grow at a compound annual growth rate (CAGR) of 17.46% from 2025 until 2030
The availability of an oral option does not change the need for lifestyle support, dietary measures, monitoring and ongoing clinical follow-up, he says